On Friday, Artiva Biotherapeutics Inc (NASDAQ: ARTV) opened higher 13.97% from the last session, before settling in for the closing price of $1.79. Price fluctuations for ARTV have ranged from $1.47 to $17.31 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -64.01%. Company’s average yearly earnings per share was noted 43.44% at the time writing. With a float of $12.30 million, this company’s outstanding shares have now reached $24.36 million.
Let’s determine the extent of company efficiency that accounts for 89 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Artiva Biotherapeutics Inc (ARTV) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Artiva Biotherapeutics Inc is 49.52%, while institutional ownership is 63.60%. The most recent insider transaction that took place on Jul 22 ’24, was worth 99,999,996. In this transaction Director of this company bought 8,333,333 shares at a rate of $12.00, taking the stock ownership to the 8,693,579 shares. Before that another transaction happened on Jul 22 ’24, when Company’s 10% Owner bought 833,333 for $12.00, making the entire transaction worth $9,999,996. This insider now owns 1,182,054 shares in total.
Artiva Biotherapeutics Inc (ARTV) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 43.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.59% during the next five years compared to -64.01% drop over the previous five years of trading.
Artiva Biotherapeutics Inc (NASDAQ: ARTV) Trading Performance Indicators
Check out the current performance indicators for Artiva Biotherapeutics Inc (ARTV). In the past quarter, the stock posted a quick ratio of 13.93.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.98, a number that is poised to hit -0.81 in the next quarter and is forecasted to reach -3.20 in one year’s time.
Technical Analysis of Artiva Biotherapeutics Inc (ARTV)
Looking closely at Artiva Biotherapeutics Inc (NASDAQ: ARTV), its last 5-days average volume was 0.39 million, which is a jump from its year-to-date volume of 0.24 million. As of the previous 9 days, the stock’s Stochastic %D was 92.99%.
During the past 100 days, Artiva Biotherapeutics Inc’s (ARTV) raw stochastic average was set at 11.24%, which indicates a significant decrease from 95.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.11 in the past 14 days, which was lower than the 0.34 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.92, while its 200-day Moving Average is $6.60. However, in the short run, Artiva Biotherapeutics Inc’s stock first resistance to watch stands at $2.15. Second resistance stands at $2.26. The third major resistance level sits at $2.45. If the price goes on to break the first support level at $1.85, it is likely to go to the next support level at $1.66. Should the price break the second support level, the third support level stands at $1.55.
Artiva Biotherapeutics Inc (NASDAQ: ARTV) Key Stats
There are currently 24,363K shares outstanding in the company with a market cap of 49.70 million. Presently, the company’s annual sales total 250 K according to its annual income of -65,370 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -20,310 K.
